top of page

CHEMOTHERAPY PROTOCOLS AGGRESSIVE MYELOMA
DCEP
DCEP
DCEP Dosing Low to high based on toxicity profile patient can handle depending on risk factors, formulated by patient's oncologist.
CYCLOPHOSPHAMIDE (250;300;400 mg/m2/day) +
ETOPOSIDE (25;30;40 mg/md/day) +
CISPLATIN (7.5;10;15 mg/m2/day) +
DEXAMETHASONE 40 mg (D 1-4) 28 DAY CYCLE
DCEP (300/30/7.5)
VDCEP
VDCEP
VELCADE / BORTEZOMIB 1.3MG/M2 (D 1,4,8,11) + DCEP
DT PACE / VDT PACE
VDT PACE
VTD-PACE (INDUCTION)
VELCADE 1MG/M2 SQ (D 1,4,8,&11) +
THALIDOMIDE 200MG (D 4-7) + DEX 40MG (D 4-7) +
(CISPLATIN 10MG/M2 + ADRIA 10MG/M2 + ETOPOSIDE 40MG/M2 +CYTOXAN 400MG/M2) (D 4-7)
VTD-PACE (CONSOLIDATION)
VELCADE 1 MG/M2 SQ (D 1,4,8,&11) +
THALIDOMIDE (D 1-4) + DEX 40MG (D 1-4) +
(CISPLATIN 7.5MG/M2 + ADRIA 7.5MG/M2 + ETOPOSIDE 30MG/M2 +CYTOXAN 300MG/M2) (D 1-4)
bottom of page